Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Anna A. Shishova"'
Autor:
Alexander S. Yakovlev, Ilmira K. Belyaletdinova, Lyudmila N. Mazankova, Elmira R. Samitova, Ismail M. Osmanov, Nataly V. Gavelya, Viktor P. Volok, Ekaterina S. Kolpakova, Anna A. Shishova, Natalia A. Dracheva, Liubov I. Kozlovskaya, Galina G. Karganova, Aydar A. Ishmukhametov
Publikováno v:
International Journal of Infectious Diseases, Vol 116, Iss , Pp 331-338 (2022)
Objectives: This study aimed to estimate the impact of the COVID-19 pandemic on the circulation of non-SARS-CoV-2 respiratory viruses and the clinical characteristics of COVID-19 in hospitalized children. Methods: A total of 226 and 864 children admi
Externí odkaz:
https://doaj.org/article/c4f1cff2e6704360b8d62c8e83062f11
Autor:
Ilya V. Gordeychuk, Liubov I. Kozlovskaya, Aleksandra A. Siniugina, Nadezhda V. Yagovkina, Vladimir I. Kuzubov, Konstantin A. Zakharov, Viktor P. Volok, Maria S. Dodina, Larissa V. Gmyl, Natalya A. Korotina, Rostislav D. Theodorovich, Yulia I. Ulitina, Dmitry I. Vovk, Marina V. Alikova, Anna A. Kataeva, Anna V. Kalenskaya, Irina V. Solovjeva, Elena V. Tivanova, Larissa Y. Kondrasheva, Antonina A. Ploskireva, Vasiliy G. Akimkin, Ksenia A. Subbotina, Georgy M. Ignatyev, Anastasia K. Korduban, Elena Y. Shustova, Ekaterina O. Bayurova, Alla S. Zhitkevich, Daria V. Avdoshina, Anastasia N. Piniaeva, Anastasia A. Kovpak, Liliya P. Antonova, Yulia V. Rogova, Anna A. Shishova, Yury Y. Ivin, Svetlana E. Sotskova, Konstantin A. Chernov, Elena G. Ipatova, Ekaterina A. Korduban, Aydar A. Ishmukhametov
Publikováno v:
Viruses, Vol 15, Iss 9, p 1828 (2023)
We present the results of a randomized, double-blind, placebo-controlled, multi-center clinical trial phase I/II of the tolerability, safety, and immunogenicity of the inactivated whole virion concentrated purified coronavirus vaccine CoviVac in volu
Externí odkaz:
https://doaj.org/article/888b158eaf434d709bf07e578aead9e6
Autor:
Liubov I. Kozlovskaya, Anastasia N. Piniaeva, Georgy M. Ignatyev, Ilya V. Gordeychuk, Viktor P. Volok, Yulia V. Rogova, Anna A. Shishova, Anastasia A. Kovpak, Yury Yu. Ivin, Liliya P. Antonova, Kirill M. Mefyod, Lyubov S. Prokosheva, Anna S. Sibirkina, Yuliya Yu. Tarasova, Ekaterina O. Bayurova, Olga S. Gancharova, Victoria V. Illarionova, Grigory S. Glukhov, Olga S. Sokolova, Konstantin V. Shaitan, Anastasia M. Moysenovich, Stanislav A. Gulyaev, Tatiana V. Gulyaeva, Andrey V. Moroz, Larissa V. Gmyl, Elena G. Ipatova, Mikhail P. Kirpichnikov, Alexey M. Egorov, Aleksandra A. Siniugina, Aydar A. Ishmukhametov
Publikováno v:
Emerging Microbes and Infections, Vol 10, Iss 1, Pp 1790-1806 (2021)
The unprecedented in recent history global COVID-19 pandemic urged the implementation of all existing vaccine platforms to ensure the availability of the vaccines against COVID-19 to every country in the world. Despite the multitude of high-quality p
Externí odkaz:
https://doaj.org/article/25dd68ffe74e41b1a33bb195f5965272
Autor:
Nadezhda V. Yagovkina, Lev M. Zheleznov, Ksenia A. Subbotina, Andrey A. Tsaan, Liubov I. Kozlovskaya, Ilya V. Gordeychuk, Anastasia K. Korduban, Yury Y. Ivin, Anastasia A. Kovpak, Anastasia N. Piniaeva, Anna A. Shishova, Elena Y. Shustova, Yusuf K. Khapchaev, Galina G. Karganova, Alexandra A. Siniugina, Tatiana V. Pomaskina, Aleksandr A. Erovichenkov, Konstantin Chumakov, Aydar A. Ishmukhametov
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundEffective response to emerging pandemic threats is complicated by the need to develop specific vaccines and other medical products. The availability of broadly specific countermeasures that could be deployed early in the pandemic could sign
Externí odkaz:
https://doaj.org/article/bbeca342ee3848b59babc5aa3a6847f5
Autor:
Maria A. Prostova, Elena Smertina, Denis V. Bakhmutov, Anna A. Gasparyan, Elena V. Khitrina, Marina S. Kolesnikova, Anna A. Shishova, Anatoly P. Gmyl, Vadim I. Agol
Publikováno v:
Viruses, Vol 11, Iss 5, p 479 (2019)
Replication of RNA viruses is generally markedly error-prone. Nevertheless, these viruses usually retain their identity under more or less constant conditions due to different mechanisms of mutation tolerance. However, there exists only limited infor
Externí odkaz:
https://doaj.org/article/0063d7e59bee435089bc20ac46e78a53
Autor:
Dmitry V. Danilov, Olga A. Shmeleva, Alexander S. Lunin, Liubov I. Kozlovskaya, Anastasia N. Piniaeva, Anna A. Shishova
Publikováno v:
Medical academic journal. 2:163-169
BACKGROUND: SARS-CoV-2 vaccine immunogenicity is evaluated in neutralization test with live virus. It is performed in a biosafety level 3 zone because requires live virus stage. Therefore, control laboratories should be certified for this class of wo
Autor:
Anna A. Shishova, Victoria S. Baryshnikova, Maya Yu. Ermakova, Yuriy V. Turchenko, Alena V. Dereventsova, Kseniya V. Fominykh
Publikováno v:
Medical academic journal. 2:269-276
BACKGROUND: The emergence of new variants of the SARS-CoV-2 virus at the end of 2020, which became a source of increased risk for global public health, prompted the study of their molecular biological characteristics and pathogenic effects. It is kno
Publikováno v:
Высшее образование в России, Vol 0, Iss 12, Pp 141-144 (2016)
Aiming at improving the quality of teaching mathematics at higher educational institutions authors discuss one of the instruments - workbook complexes which can beimplemented as an element of educational and methodical complex as well as one of the a
Externí odkaz:
https://doaj.org/article/5e9c1893c99146c5a62b139496f6153a
Autor:
Yury Ivin, Dmitry V. Bagrov, Konstantin V. Shaitan, Daniil Litvinov, Anastasia Kovpak, Viktor P. Volok, Alexey M. Egorov, Dmitry I. Osolodkin, Olga Sokolova, Anastasia Piniaeva, M. G. Karlova, Anna A. Shishova, Liubov I. Kozlovskaya, Aydar A. Ishmukhametov, Andrey Moiseenko, Mikhail P. Kirpichnikov, G. S. Glukhov, Petr Zaitsev, Alexey S. Oksanich
Publikováno v:
Microscopy Research and Technique
The severe COVID‐19 pandemic drives the research toward the SARS‐CoV‐2 virion structure and the possible therapies against it. Here, we characterized the β‐propiolactone inactivated SARS‐CoV‐2 virions using transmission electron microsco
Autor:
Aydar A Ishmukhametov, Aleksandra A Siniugina, Nadezhda V Yagovkina, Vladimir I Kuzubov, Konstantin A Zakharov, Viktor P Volok, Maria S Dodina, Larissa V Gmyl, Natalya A Korotina, Rostislav D Theodorovich, Yulia I Ulitina, Andrey A Tsaan, Tatiana V Pomaskina, Anna V Kalenskaya, Irina V Solovjeva, Elena V Tivanova, Larissa Y Kondrasheva, Antonina A Ploskireva, Vasiliy G Akimkin, Ksenia A Subbotina, Georgy M Ignatyev, Anastasia K Korduban, Elena Y Shustova, Ekaterina O Bayurova, Alla S Kondrashova, Darya V Avdoshina, Anastasia N Piniaeva, Anastasia A Kovpak, Liliya P Antonova, Yulia V Rogova, Anna A Shishova, Yury Y Ivin, Svetlana E Sotskova, Konstantin A Chernov, Elena G Ipatova, Ekaterina A Korduban, Liubov I Kozlovskaya, Ilya V Gordeychuk
We present the results of a randomized, double-blind, placebo-controlled, multi-center clinical trial of the tolerability, safety, and immunogenicity of the inactivated whole virion concentrated purified coronavirus vaccine CoviVac in adult volunteer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fa7f5e2e5807fe5981592d7795102a1
https://doi.org/10.1101/2022.02.08.22270658
https://doi.org/10.1101/2022.02.08.22270658